Abstract-Systemic arterial pressure was markedly increased in the early phase of cerebral ischemia induced by bilateral carotid artery occlusion (BCAO) in stroke-prone spon taneously hypertensive rats (SHRSP). The elevated level of arterial pressure was gradually returned to the initial level, and hypotension followed in the late phase. Severe neurological symptoms such as "ischemic seizure", dyspnea and coma were developed in the late phase. All SHRSP died within 6 hr after BCAO. The heart rate continued to increase during the brain ischemia.
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Cardiac arrhythmias, significant increases in plasma levels of creatine phosphokinase (CPK) and CPK-MB isozyme and disruption of myo fibrils were observed after BCAO, particularly after the development of ischemic seizure. In contrast, in stroke-resistant SHR (SHRSR) and Wistar-Kyoto rats (WKY), ischemic seizure did not develop, yet all died within 8 hr after BCAO. Arterial pressures were moderately increased and never decreased to below the initial levels during the obser vation periods.
Increases in CPK-MB isozyme activities in plasma from SHRSR and WKY were not detected.
Pretreatments with propranolol and reserpine inhibited the increases in heart rate, reduced the frequency of arrhythmias and prolonged the survival time following BCAO in SHRSP.
Our results indicate that cardiac dysfunction, which is a consequence of the cerebral ischemia, may be one of the causes of death following BCAO in SHRSP.
Bilateral carotid artery occlusion (BCAO) causes a marked brain ischemia in spon taneously hypertensive rats (SHR) and a stroke-prone strain of SHR (SHRSP) (1-4). In both these strains of SHR, after BCAO, cerebral anaerobic metabolites were increased and adenosine triphosphate were decreased, leading to the development of various neuro logical symptoms. Clinical studies (5-11) in patients with acute cerebrovascular accidents demonstrated a high incidence of cardiac ar rhythmias and other electrocardiographic (ECG) abnormalities, histological changes in the myocardium, and elevated levels of serum cardiac enzymes such as creatine phos phokinase (CPK) and lactate dehydrogenase (LDH) . Dimant and Grob (10) reported that twenty-nine percent of the patients with stroke had raised serum enzyme levels, and those with elevated CPK levels had a higher incidence of ECG abnormality as well as a higher mortality than those with normal CPK levels. 
Materials and Methods
General: Male stroke-prone spon taneously hypertensive rats (SHRSP), a stroke-resistant SHR (SHRSR) and nor motensive Wistar-Kyoto rats (WKY), 10-11 weeks of age, were used. The rats had been raised in our laboratories and given a laboratory chow, CE-2, Japan Clea and tap water ad libitum. Under light ether anesthesia, the bilateral common carotid arteries were exposed through a ventral midline incision in the neck and were separated carefully from vagosympathetic trunks. When the rats had recovered from ether anesthesia after 5 min, the arteries were simultaneously ligated with silk sutures, and the skin incision was closed with steel clips. Neurological symptoms after BCAO were scored as follows: 0, normal; 1, slight decrease in spontaneous motor activity; 2, no ambulation and weakness of hindlimb; 3, weakness of all four limbs, and presence of righting reflex; 4, weakness of all limbs, and no lighting reflex; 5, pilo erection and tremor; 6, jumping and/or seizure (ischemic seizure); 7, dyspnea or coma; 8, death.
Hemodynamics and neurological changes: Systemic arterial pressure, heart rate and ischemic neurological symptoms following BCAO were examined in SHRSP (N=8), SHRSP (N=6) and WKY (N=6). The femoral artery was cannulated with a polyethylene tube (PE-10) filled with sodium heparin (100 IU/ml in 0.9% NaCI). This tube was reflected dorsally and anteriorly, led subcu taneously to the back of the neck, and exteriorized through a small skin puncture. The catheter was flushed occasionally with saline containing 100 IU sodium heparin per ml to prevent blood clotting. The rats were placed individually in a transparent plastic cylinder (22 cm diam., 55 cm height). Mean arterial pressure was measured via a femoral arterial catheter with a pressure transducer and polygraph (RM-45, Nihon Koden, Tokyo). Heart rate was calculated from the blood pressure tracing. Thirty minutes after surgery, mean arterial pressure and heart rate were recorded as the initial values. The changes in blood pressure and heart rate and the development of neuro logical symptoms were observed for 8 hr and at 24 hr after BCAO. Because jumping and/or seizure was the most unequivocal symptom (termed ischemic seizure), the time which elapsed until onset of the ischemic seizure and death were recorded. In rats with no ischemic seizure up to 8 hr, the time was recorded as 480 min. 
Results

Hemodynamics and neurological changes:
Mean arterial pressures before BCAO were 166±5, 126±4 and 107±2 mmHg in SHRSP, SHRSR and INKY, respectively (Table 1) . Heart rates were similar in the three strains.
I n S H R S P, there were observed a decrease in spontaneous motor activity and a marked weakness of all the limbs (score 1-3) within 60 min after BCAO. The time required for onset of ischemic seizure (score 6) was 112±10 min (Table 1) . Thereafter, the animals became dyspneic or comatose (score 7) and died within 6 hr after BCAO, with an average death time of 248±16 min. In contrast, in SHRSR and WKY, ischemic seizure did not develop, yet all died within 8 hr after BCAO. Some of SHRSR and WKY showed only slight neurological abnormalities (score 1-3). Table 1 . Initial mean arterial pressure (MAP), heart rate (HR) and time required for onset of ischemic seizure and survival time following bilateral carotid artery occlusion (BCAO) in WKY, SHRSR and SHRSP Each point is the mean± S.E.M. of 8 rats. Time-course of MAP and HR changes are constructed from three periods left, the first 1-hr period following BCAO; center, the 30-min period before and after the first development of ischemic seizure; right, the 1-hr period before death following BCAO. MAR and H R were deter mined every 10 min in each period. Time-course of arterial pressure changes following BCAO in SHRSP is shown in Fig. 1 , and a representative recording is given in Fig. 2 . In the early phase of cerebral ischemia, mean arterial pressure rose mark edly immediately after BCAO, and reached a level of 222±3 mmHg 10 min later. The elevated level lasted for about 30 min and then returned to the initial level within 90 min. In the late phase of cerebral ischemia, transient but marked elevation of blood pressure was observed at the time when the ischemic seizure developed. The average increment was about 100 mmHg at the first development of the seizure (Fig. 1 ) . After the repeated occurrence of ischemic seizure, arterial pressure was further decreased to hypotensive levels. Heart rate continued to increase during the brain ischemia (Fig. 1 ) . Arterial pressure and heart rate in SHRSR and WKY were moderately increased and never decreased to below the initial levels. In SHRSR, mean arterial pressure gradually increased to 175-180 mmHg at 40-80 min after BCAO and returned to the initial level within 8 hr. In WKY, the arterial pressure slightly increased to a level of about 130 mmHg at 20 min after BCAO. The elevated level continued during the observation period. Heart rate in these strains of rats slightly increased, but returned to the initial level within 3 hr.
Plasma enzyme activities:
Alterations in plasma LDH and CPK activities and LDH and CPK isozyme patterns after BCAO in SHRSP, SHRSR and WKY are shown in Table 2 and Figs. 3 and 4. In SHRSP, both total LDH and CPK levels were significantly increased after BCAO. Increases in the levels were much more pronounced at 3 than 1 hr after BCAO. LDH1 and LDH2 isozymes not detectable in the plasma of sham-operated controls, were identified (Fig. 3) . Moreover, a marked increase in CPK-MB isozyme was observed in SHRSP, particularly in the SHRSP with severe neurological deficits (score 7) and hypotension (Figs. 4 and 5). Total LDH and CPK levels in WKY and SHRSR were increased slightly but sig nificantly. Increases in cardiac enzymes such as LDH, and LDH2 isozymes or CPK-MB isozyme in plasma from SHRSR and WKY were nil (Figs. 3 and 4) .
Electrocardiogram: A transient but marked fall in blood pressure (Fig. 2 , at 50 min of BCAO) sometimes followed BCAO in the SHRSP. When the transient and precipitous fall of blood pressure (Fig. 6, left) and seizures (Fig. 6 , right) occurred, cardiac rhythm disturbances such as single and mutiple ventricular premature beats were observed. These arrhythmias were noted in every SHRSP so-tested. 
Discussion
The pathogenetic mechanism of cerebral ischemia after BCAO in SH R has been studied by Fujishima et al. (1-3, 12, 13 propranolol. Bradycardia and apnea, however. could not be observed in the early phase of brain ischemia in SHRSP. This difference in cardiovascular response to cerebral ischemia seems to be due to the difference in the type of cerebral ischemia. In the previous studies, most experiments were performed under the condition of almost complete ischemia. In SHRSP with BCAO, the regional blood flow in the cerebral cortex was decreased to about 20% of the basal value and that in the brainstem including the medulla oblongata did not change in the early phase of cerebral ischemia (4). Further work will be needed to elucidate the detailed neural mechanism involved in the cardiovascular responses to cerebral ischemia following BCAO in SHRSP .
Knowledge of the level of serum cardiac enzymes (LDH, CPK etc.) is pertinent to evaluate the extent of cardiac damage. Of these enzymes, the serum levels of CPK and CPK-MB isozyme proved to be the most usefull indicators of myocardial damage (24, 25) . A growing body of clinical and experi mental data revealed that cerebrovascular lesions exhibit a high incidence of ECG abnormalities and arrhythmias with elevated serum levels of cardiac enzymes (11, 12, 26, 27) . Plasma levels of LDH and CPK were markedly increased after BCAO in SHRSP. The degree of increases in CPK-MB tended to be correlate with severity of the neurological symptoms. In addition, cardiac arrhythmias was detected during the period of brain ischemia, particularly in the late phase. These findings strongly suggest that brain ischemia induces myocardial dysfunction in SHRSP with BCAO. In fact, disruption of myofibrils was found in the late phase of cerebral ischemia in SHRSP.
The marked elevation of systemic arterial pressure in SHRSP with BCAO was followed by gradual return to the initial level in the early phase of brain ischemia. After repeated occurrence of ischemic seizure, arterial pres sure was further decreased to a hypotensive level in the late phase. It should be stressed that cardiac rhythm disturbances and release of CPK-MB isozyme from the myocardium were detected in the early phase of brain ischemia. Moreover, focal myocardial ne crosis and fibrosis were observed in SHRSP with and without BCAO. Yamori et al. (28) have already reported that genetic hyper tension accompanied by left ventricular hyper trophy with thickening of coronary arterial wall may be a pathogenetic factor for myocardial lesions or myocardial infarction in SHRSP. These pathophysiological changes in the heart of SH RSP may explain the increased susceptibility to myocardial damage due to cerebral ischemia, leading to the development of arrhythmias, the release of cardiac enzymes, and the breakdown of pressor response (compensatory response) in the SHRSP.
It has been reported (28-30) that hearts subjected to coronary artery occlusion are hyperreactive to arrhythmogenic effects of catecholamines and that reserpine and pro pranolol prevent the occurrence of cardiac arrhythmias in such hearts. These drugs also limited the enzyme release from the myo cardium in the experimental ischemic and hypoxic hearts (31-34 Res. 3, 433-440 (1969) 39) Hawkins, W.E. and Clower, B.R.: Myocardial damage after head trauma and simulated intra cranial hemorrhage in mice: the role of the autonomic nervous system. Cardiovasc. Res. 5, 524-529 (1971) 
